Stockreport

Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio

Assertio Holdings, Inc.  (ASRT) 
Last assertio holdings, inc. earnings: 3/9 04:02 pm Check Earnings Report
PDF -- Adds Portfolio of Branded Products with $48.9 million in 2025 Net Sales and an Established Commercial Presence ---- SYMPAZAN® Establishes a Neurology Rare Disease Foo [Read more]